BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 19667708)

  • 1. beta-Blockers and hypertension: a therapeutic reappraisal.
    Panjrath GS; Sawhney S; Messerli FH
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):26-33. PubMed ID: 19667708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The rational selection of beta-blockers in the treatment of hypertension].
    Ter Arkh; 1999; 71(2):57-64. PubMed ID: 10222557
    [No Abstract]   [Full Text] [Related]  

  • 3. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW
    Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta blockers in the treatment of arterial hypertension].
    Spinar J; VĂ­tovec J
    Cas Lek Cesk; 1998 May; 137(9):278-81. PubMed ID: 9650357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of beta-adrenergic receptor blocking agents in hypertensive diseases: personal thoughts as the controversy persists.
    Frohlich ED
    Ther Adv Cardiovasc Dis; 2009 Dec; 3(6):455-64. PubMed ID: 19897523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-blockers for hypertension: are they going out of style?
    Che Q; Schreiber MJ; Rafey MA
    Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?].
    Sawicki PT; Berger M
    Dtsch Med Wochenschr; 1992 May; 117(22):875-9. PubMed ID: 1350758
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta blockers in primary hypertension: Do age and type of beta-blocker matter?
    Lindholm LH; Carlberg B; Samuelsson O
    J Hypertens; 2006 Nov; 24(11):2143-5. PubMed ID: 17053530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Beta blockers for hypertension. No negative influence on insulin resistance].
    MMW Fortschr Med; 2002 Feb; 144(8):50. PubMed ID: 11910826
    [No Abstract]   [Full Text] [Related]  

  • 10. Beta-blockers as first-line antihypertensive therapy the crumbling continues.
    Lavie CJ; Messerli FH; Milani RV
    J Am Coll Cardiol; 2009 Sep; 54(13):1162-4. PubMed ID: 19761937
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-blockers and hypertension.
    Cruickshank JM
    J Am Coll Cardiol; 2009 Jun; 53(22):2105-6; author reply 2106-7. PubMed ID: 19477369
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents.
    Sarafidis PA; Bakris GL
    J Hypertens; 2007 Jan; 25(1):249-52; author reply 252-3. PubMed ID: 17143201
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta blockers 1984. Part 2.
    Wing LM
    Aust Fam Physician; 1984 Aug; 13(8):604, 606, 608. PubMed ID: 6149740
    [No Abstract]   [Full Text] [Related]  

  • 14. The long and the short of it.
    Kostis WJ; Chan AT; Dunn JM; Henrikson CA
    Am J Med; 2010 Jul; 123(7):606-8. PubMed ID: 20609683
    [No Abstract]   [Full Text] [Related]  

  • 15. [Principal pharmacological properties of different beta-blockers, possibilities and new perspectives of their uses].
    Antelava N; Antelava A; Pachkoria K; Pirtskhalaishvili N
    Georgian Med News; 2006 Dec; (141):38-46. PubMed ID: 17261885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different metabolic effects of selective and nonselective beta-blockers rather than mere heart rate reduction may be the mechanisms by which beta-blockade prevents cardiovascular events.
    Fragasso G; Cera M; Margonato A
    J Am Coll Cardiol; 2009 Jun; 53(22):2105; author reply 2106-7. PubMed ID: 19477370
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers should remain as first-line therapy in the management of hypertension.
    Krum H
    Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-blocker-induced heart rate reduction: too simplistic to explain the deleterious effects of beta-blockers.
    Laurent S; Boutouyrie P
    J Am Coll Cardiol; 2009 Jun; 53(22):2103-4; author reply 2106-7. PubMed ID: 19477367
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypertensive treatment, when beta blockers can not be used].
    Rasmussen K; Jensen HA
    Ugeskr Laeger; 1980 Jun; 142(24):1580. PubMed ID: 6106310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 30.